STEADY-STATE PHARMACOKINETICS OF TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE

被引：0

作者：

CUTLER, NR

SEDMAN, AJ

PRIOR, P

UNDERWOOD, BA

SELEN, A

BALOGH, L

KINKEL, AW

GRACON, SI

GAMZU, ER

机构：

[1] CALIF CLIN TRIALS,BEVERLY HILLS,CA

[2] PARKE DAVIS & CO,PHARMACEUT RES,ANN ARBOR,MI 48106

来源：

PSYCHOPHARMACOLOGY BULLETIN | 1990年 / 26卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：231 / 234

页数：4

共 10 条

[1]

DAVIES P, 1981, STRATEGIES DEV EFFEC, P19

[2] 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE (THA), AN ALLEGED DRUG FOR THE TREATMENT OF ALZHEIMERS-DISEASE, INHIBITS ACETYLCHOLINESTERASE ACTIVITY AND SLOW OUTWARD K+ CURRENT [J].

DRUKARCH, B ;

KITS, KS ;

VANDERMEER, EG ;

LODDER, JC ;

STOOF, JC .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 141 (01) :153-157

[3]

EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487

[4] INHIBITION OF CHOLINESTERASES BY TETRAHYDROAMINACRIN [J].

HEILBRONN, E .

ACTA CHEMICA SCANDINAVICA, 1961, 15 (06) :1386-&

[5]

MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939

[6]

SELEN A, 1989, UNPUB RES DATA FILE

[7]

SELEN A, 1988, PHARM RES-DORDR, V5, pS171

[8]

SELEN A, 1988, PHARM RES-DORDR, V5, pS218

[9]

SHERMAN K A, 1987, Society for Neuroscience Abstracts, V13, P266

[10] ORAL TETRAHYDROAMINOACRIDINE IN LONG-TERM TREATMENT OF SENILE DEMENTIA, ALZHEIMER TYPE [J].

SUMMERS, WK ;

MAJOVSKI, LV ;

MARSH, GM ;

TACHIKI, K ;

KLING, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (20) :1241-1245

← 1 →